Viewing Study NCT02565758


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-02-26 @ 7:24 PM
Study NCT ID: NCT02565758
Status: COMPLETED
Last Update Posted: 2019-04-05
First Post: 2015-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module